Latest Regulatory Approvals News

Page 7 of 321
The Australian Competition and Consumer Commission has signalled no objection to Rubik Australia's full acquisition of Qube Holdings, paving the way for the scheme's next legal and regulatory steps. The Qube board also plans a fully franked special dividend, contingent on scheme approval.
Victor Sage
Victor Sage
18 June 2026
SDI Limited has satisfied key regulatory approvals and financing conditions for its proposed A$1.40 per share acquisition by a Sinocera-controlled bidder, with shareholder and court approvals still pending.
Ada Torres
Ada Torres
17 June 2026
Macquarie Group Limited has announced a quarterly distribution of AUD 1.5598 per MQGPG capital note, payable in September 2026. The distribution is partly franked at 35%, reflecting a total annualised yield of 6.19%.
Victor Sage
Victor Sage
17 June 2026
Bass Oil has secured full ownership of the Vanessa gas field in the Cooper Basin, aiming to resume gas sales by year-end after recommissioning the facility and pipeline.
Maxwell Dee
Maxwell Dee
17 June 2026
Golden Dragon Mining has applied for a new tenement just 1.5 km from Westgold’s Big Bell Gold Mine, extending its landholding in Western Australia’s Murchison Goldfields to about 619 km². The move boosts exposure to a prolific gold belt with multiple high-priority targets, including the drill-ready Jeffrey Well prospect.
Maxwell Dee
Maxwell Dee
17 June 2026
Zinc of Ireland (ASX: ZMI) has finalised its acquisition of Meclex, securing two hydrometallurgical technologies aimed at disrupting zinc and lead processing with low-emission methods. Backed by a fresh A$5.5 million placement, ZMI is accelerating pilot plant development and exploration at its Kildare project.
Maxwell Dee
Maxwell Dee
17 June 2026
Neurizon Therapeutics has secured a critical five-year supply agreement with Elanco Animal Health for GMP-grade monepantel, underpinning the commercialisation readiness of its lead ALS drug candidate NUZ-001.
Ada Torres
Ada Torres
17 June 2026
Island Pharmaceuticals has won a key regulatory boost as the US FDA granted Orphan Drug Designation to Galidesivir for post-exposure prophylaxis of Marburg virus disease, enhancing its commercial and development prospects.
Victor Sage
Victor Sage
17 June 2026
Lithium Universe (ASX: LU7) has completed the detailed process flow sheet for a novel hydrometallurgical technology licensed from the University of Edinburgh to extract gold and copper from electronic waste. The low-temperature, reagent-recycling method aims to disrupt traditional smelting with environmental and cost benefits.
Victor Sage
Victor Sage
17 June 2026
Toro Energy’s takeover by IsoEnergy has officially become effective following Federal Court approval, setting key dates for share trading suspension and scheme implementation.
Maxwell Dee
Maxwell Dee
16 June 2026
Qube Holdings shareholders convened to endorse a $5.20 per share acquisition scheme by Rubik Australia, valuing the logistics firm at $9.3 billion equity and $11.7 billion enterprise value. The deal awaits key regulatory approvals and a rescheduled court hearing before implementation.
Victor Sage
Victor Sage
16 June 2026
PC Gold has reported compelling new gold assay results from its Spring Hill project, alongside a strategic tenement acquisition that expands its landholding by 68km². The company is ramping up exploration with four rigs and a $22 million cash buffer, setting the stage for resource growth beyond the imminent update.
Maxwell Dee
Maxwell Dee
16 June 2026